Michael Davidson to Food-Drug Interactions
This is a "connection" page, showing publications Michael Davidson has written about Food-Drug Interactions.
Connection Strength
0.215
-
Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non-human primate studies and clinical trials. Pharmacol Res Perspect. 2024 12; 12(6):e70010.
Score: 0.215